| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Australia | 3 | |
| #3 | Brazil | 3 | |
| #4 | Canada | 3 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | China | 2 | |
| #7 | Cuba | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | Mexico | 2 | |
| #10 | Taiwan | 2 | |
| #11 | WIPO (World Intellectual Property Organization) | 2 | |
| #12 | Israel | 1 | |
| #13 | Japan | 1 | |
| #14 | New Zealand | 1 | |
| #15 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wu Chengbin | 27 |
| #2 | Chengbin Wu | 5 |
| Publication | Filing date | Title |
|---|---|---|
| EP3500301A1 | Monovalent asymmetric tandem fab bispecific antibodies | |
| AU2017312974A1 | Monovalent asymmetric tandem Fab bispecific antibodies | |
| MX2018009581A | Fabs-in-tandem immunoglobulin and uses thereof. | |
| ZA201603596B | Fabs-in-tandem immunoglobulin and uses thereof | |
| EP3089994A1 | Fabs-in-tandem immunoglobulin and uses thereof |